308 related articles for article (PubMed ID: 19489874)
21. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1).
Zenaty D; Bretones P; Lambe C; Guemas I; David M; Léger J; de Roux N
Mol Cell Endocrinol; 2006 Jul; 254-255():78-83. PubMed ID: 16757108
[TBL] [Abstract][Full Text] [Related]
22. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
[TBL] [Abstract][Full Text] [Related]
23. Loss of function mutations of the GnRH receptor: a new cause of hypogonadotropic hypogonadism.
de Roux N; Young J; Misrahi M; Schaison G; Milgrom E
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():267-75. PubMed ID: 10698591
[TBL] [Abstract][Full Text] [Related]
24. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
[TBL] [Abstract][Full Text] [Related]
25. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
Pitteloud N; Quinton R; Pearce S; Raivio T; Acierno J; Dwyer A; Plummer L; Hughes V; Seminara S; Cheng YZ; Li WP; Maccoll G; Eliseenkova AV; Olsen SK; Ibrahimi OA; Hayes FJ; Boepple P; Hall JE; Bouloux P; Mohammadi M; Crowley W
J Clin Invest; 2007 Feb; 117(2):457-63. PubMed ID: 17235395
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetics of Kallmann syndrome: an update].
Fu C; Feng Z; Liu RZ
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
[TBL] [Abstract][Full Text] [Related]
27. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.
Gach A; Pinkier I; Szarras-Czapnik M; Sakowicz A; Jakubowski L
Reprod Biol Endocrinol; 2020 Jan; 18(1):8. PubMed ID: 31996231
[TBL] [Abstract][Full Text] [Related]
28. The role of gene defects underlying isolated hypogonadotropic hypogonadism in patients with constitutional delay of growth and puberty.
Vaaralahti K; Wehkalampi K; Tommiska J; Laitinen EM; Dunkel L; Raivio T
Fertil Steril; 2011 Jun; 95(8):2756-8. PubMed ID: 21292259
[TBL] [Abstract][Full Text] [Related]
29. [Genetic anomalies of the gonadotropic axis].
de Roux N; Morel Y; Hardelin JP
Rev Prat; 1999 Jun; 49(12):1277-82. PubMed ID: 10488658
[TBL] [Abstract][Full Text] [Related]
30. Hypogonadotropic hypogonadism.
Layman LC
Endocrinol Metab Clin North Am; 2007 Jun; 36(2):283-96. PubMed ID: 17543719
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic hypogonadotropic hypogonadism in a mother and her monozygotic twins born after a single embryo transfer.
Laitinen EM; Tommiska J; Dunkel L; Sankilampi U; Vaaralahti K; Raivio T
Fertil Steril; 2010 Apr; 93(6):2074.e13-6. PubMed ID: 20079901
[TBL] [Abstract][Full Text] [Related]
32. The genetics of hypogonadotropic hypogonadism.
Bhagavath B; Layman LC
Semin Reprod Med; 2007 Jul; 25(4):272-86. PubMed ID: 17594608
[TBL] [Abstract][Full Text] [Related]
33. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
[TBL] [Abstract][Full Text] [Related]
34. Isolated cryptorchidism: no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism.
Laitinen EM; Tommiska J; Virtanen HE; Oehlandt H; Koivu R; Vaaralahti K; Toppari J; Raivio T
Mol Cell Endocrinol; 2011 Jul; 341(1-2):35-8. PubMed ID: 21664240
[TBL] [Abstract][Full Text] [Related]
35. Multiplex ligation-dependent probe amplification detects DCX gene deletions in band heterotopia.
Mei D; Parrini E; Pasqualetti M; Tortorella G; Franzoni E; Giussani U; Marini C; Migliarini S; Guerrini R
Neurology; 2007 Feb; 68(6):446-50. PubMed ID: 17283321
[TBL] [Abstract][Full Text] [Related]
36. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome.
Aretz S; Stienen D; Uhlhaas S; Loff S; Back W; Pagenstecher C; McLeod DR; Graham GE; Mangold E; Santer R; Propping P; Friedl W
Hum Mutat; 2005 Dec; 26(6):513-9. PubMed ID: 16287113
[TBL] [Abstract][Full Text] [Related]
37. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
[TBL] [Abstract][Full Text] [Related]
38. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
Tommiska J; Känsäkoski J; Christiansen P; Jørgensen N; Lawaetz JG; Juul A; Raivio T
Eur J Med Genet; 2014 Jul; 57(7):345-8. PubMed ID: 24732674
[TBL] [Abstract][Full Text] [Related]
39. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
40. Genetic diagnosis of idiopathic hypogonadotrophic hypogonadism: a new point mutation in the KAL2 gene.
Entrala-Bernal C; Montes-Castillo C; Alvarez-Cubero MJ; Gutiérrez-Alcántara C; Fernandez-Rosado F; Martinez-Espίn E; Sánchez-Malo C; Santiago-Fernández P
Hormones (Athens); 2014; 13(2):280-5. PubMed ID: 24776628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
